Bottom Line: A new study assesses chemotherapy-induced peripheral neuropathy in 121 long-term survivors of childhood cancer to detail clinical, functional, neurophysiological and patient-reported outcomes of the condition.
Why The Research Is Interesting: Childhood and adolescent cancer survival rates have improved and it's important to understand the long-term effect of cancer treatment. Chemotherapy-induced peripheral neuropathy is a potentially long-lasting adverse effect of chemotherapy agents that can be toxic to peripheral nerves.
Authors: Susanna B. Park, Ph.D., of the University of Sydney, Australia, and coauthors
To read the full study, please visit the For The Media website.
(doi:10.1001/jamaneurol.2018.0963)
Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
###
To place an electronic embedded link in your story: Links will be live at the embargo time: http://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2018.0963
Media Contact
Susanna B. Park
[email protected]
@JAMANeuro
